Capital Advisors Inc Gilead Sciences, Inc. Transaction History

Capital Advisors Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $7.72 Million - $8.55 Million	-108,334 Closed	0 $0
Q2 2018 Aug 06, 2018	BUY	$64.88 - $75.68 $225,068 - $262,533	3,469 Added 3.31%	108,334 $0
Q1 2018 May 04, 2018	SELL	$72.84 - $88.8 $5.68 Million - $6.93 Million	-78,029 Reduced 42.66%	104,865 $0
Q4 2017 Jan 29, 2018	SELL	$71.15 - $83.52 $549,989 - $645,609	-7,730 Reduced 4.06%	182,894 $13.1 Million
Q3 2017 Nov 14, 2017	SELL	$72.11 - $85.47 $291,396 - $345,384	-4,041 Reduced 2.08%	190,624 $15.4 Million
Q2 2017 Aug 09, 2017	BUY	N/A	194,665	194,665 $13.8 Million

1,931

991M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Capital Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Capital Advisors Inc with notifications on news.